220 results on '"Kroon, Eugène"'
Search Results
2. Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies
3. Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies.
4. Safety and immunogenicity of a prefusion non-stabilized spike protein mRNA COVID-19 vaccine: a phase I trial
5. Liver function test abnormalities in a longitudinal cohort of Thai individuals treated since acute HIV infection
6. Preferential and persistent impact of acute HIV-1 infection on CD4⁺ iNKT cells in colonic mucosa
7. HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections
8. Decision making for invasive and non-invasive optional procedures within an acute HIV research cohort in Bangkok
9. Attitudes About Analytic Treatment Interruption (ATI) in HIV Remission Trials with Different Antiretroviral Therapy (ART) Resumption Criteria
10. Acute HIV-1 infection viremia associate with rebound upon treatment interruption
11. Brain volumetrics differ by Fiebig stage in acute HIV infection
12. Parallel but connected: Nuances of conducting behavioral and social science research alongside ethically challenging HIV remission trials
13. Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial
14. Persistent HIV transcription and variable antiretroviral drug penetration in lymph nodes during plasma viral suppression
15. Neurologic signs and symptoms frequently manifest in acute HIV infection.
16. Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities
17. Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption
18. Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial
19. Distinct mucosal and systemic immunological characteristics in transgender women potentially relating to HIV acquisition
20. Cognitive trajectories after treatment in acute HIV infection
21. Distribution of Human Immunodeficiency Virus (HIV) Ribonucleic Acid in Cerebrospinal Fluid and Blood Is Linked to CD4/CD8 Ratio During Acute HIV
22. Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis
23. Reply to Chen et al
24. Acute Retroviral Syndrome Is Associated With High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments
25. Ethics of treatment interruption trials in HIV cure research : addressing the conundrum of risk/benefit assessment
26. Brief Report: Syphilis Incidence and Effect on Viral Load, CD4, and CD4/CD8 Ratio in a Thai Cohort of Predominantly Men Who Have Sex With Men Living With HIV
27. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection
28. Corrigendum to ‘Decision making for invasive and non-invasive optional procedures within an acute HIV research cohort in Bangkok,’ [Contemporary Clinical Trials Communication (2023)101054]
29. Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology
30. Transmission dynamics among participants initiating anti-retroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand
31. Neurosyphilis During Acute HIV Infection: A CNS Immunologic and Virologic Characterization
32. Leveraging early HIV diagnosis and treatment in Thailand to conduct HIV cure research
33. Determinants of suboptimal CD4+ T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV‐1 infection
34. Productive and latent HIV infections originate in resting CD4+T cells
35. HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotype
36. Transmission dynamics among participants initiating antiretroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand
37. Immunological, Cognitive and Psychiatric Outcomes after Initiating EFV- and DTG-based Antiretroviral Therapy during Acute HIV Infection
38. HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections
39. Brief Report: Safety of Frequent Blood Sampling in Research Participants in an Acute HIV Infection Cohort in Thailand
40. Switch to dolutegravir is well tolerated in Thais with HIV infection
41. Going off antiretroviral treatment in a closely monitored HIV 'cure' trial: longitudinal assessments of acutely diagnosed trial participants and decliners
42. Immunological, Cognitive, and Psychiatric Outcomes After Initiating Efavirenz- and Dolutegravir-based Antiretroviral Therapy During Acute Human Immunodeficiency Virus Infection.
43. Clinical signs and symptoms associated with acute HIV infection from an intensely monitored cohort on 2 continents
44. Individual Differences in CD4/CD8 T-Cell Ratio Trajectories and Associated Risk Profiles Modeled From Acute HIV Infection.
45. Persons living with HIV treated in acute HIV infection report good health-related quality of life in Thailand.
46. Persons living with HIV treated in acute HIV infection report good health-related quality of life in Thailand
47. Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies
48. Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of Infection.
49. Decision Making for Invasive and Non-Invasive Optional Procedures Within an Acute HIV Research Cohort in Bangkok
50. Longitudinal Analysis of Peripheral and Colonic CD161+ CD4+ T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment Initiation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.